Under construction – not a live service
Sign in
TerminatedNo phase

Concomitant Application of TENS and NMES on Chronic Stroke

Reason given: After the G power analysis, it was determined that a total of 60 patients needed initial, 1st month and 4th month follow-ups. The study was terminated when the follow-ups of 60 patients were completed prospectively.

Key facts

Where
Istanbul, TürkiyeSee the site

Where in Türkiye

  • University of Health SciencesIstanbul, TürkiyeNo longer taking part

Trial details

Who runs it
Gaziosmanpasa Research and Education Hospital
Trial code
NCT06619262
Record updated
1 October 2024
Original description
Stroke is a cerebrovascular disorder that can lead to permanent disability and a decline in quality of life. Chronic stroke patients often experience decreased balance control, which negatively affects activities of daily living and their ability to walk independently. Studies conducted with electrical stimulation have shown that it is safe to use on humans. Today, it is frequently preferred in treatment.Read full original descriptionShow less

The Effects of Concomitant Application of TENS and NMES on Chronic Stroke Patients: A Prospective Randomized Controlled Study

Stroke is a cerebrovascular disorder that can lead to permanent disability and a decline in quality of life. Chronic stroke patients often experience decreased balance control, which negatively affects activities of daily living and their ability to walk independently. Studies conducted with electrical stimulation have shown that it is safe to use on humans. Today, it is frequently preferred in treatment.

Electrical stimulation are effective for treatment of stroke. Electrical stimulation has been used as transcutaneous nerve stimulation (TENS) and neuromuscular electrical stimulation (NMES). Both of them are effective but not sufficient. The concomitant application of TENS and NMES may achieve better results than individually application.

Inclusion: First episode of unilateral stroke with hemiparesis Stroke confirmed by CT and/or MRI Ablity to independently stand up from a chair.

Exclusion: Cerebellar or brainstem stroke Severe cognitive and communication impairment Previous surgical treatment history on the affected extremity Complication with severe heart, lung, liver, kidney, or infectious disease Presence of a cardiac pacemaker Orthopedic disease affecting sit-to-stand movement Inability to understand and follow verbal commands Peripheral or central nervous system dysfunction.

ClinicalTrials.gov NCT06619262